EVERSANA proudly announces our participation at the 61st American Society of Hematology Annual Meeting & Exposition in Orlando, Florida. The ASH Annual Meeting is the world’s most comprehensive hematology event of the year and will provide an invaluable opportunity to review thousands of scientific abstracts highlighting updates in the hottest topics in hematology. Network with top minds in the field and a global community of more than 25,000 hematology professionals from every subspecialty.
From December 7-9, our team of experts will present 5 Poster Abstracts in Hall B, Level 2 of the Orange Country Convention Center:
SATURDAY, DECEMBER 7 | 5:30 PM-7:30 PM
2167 Relationship between Vaso-Occlusive Crises and Important Complications in Sickle Cell Disease Patients
SUNDAY, DECEMBER 8 | 6:00 PM-8:00 PM
3066 Outcomes of Patients with t(11;14) Multiple Myeloma: An International Myeloma Working Group Multicenter Study
3012 Persistent Red Blood Cell (RBC) Transfusion Is Associated with Increased Mortality Risk in Transfusion-Dependent (TD) Patients with Myelodysplastic Syndromes (MDS) with Ring Sideroblasts (RS+)
MONDAY, DECEMBER 9 | 6:00 PM-8:00 PM
4737 A Discrete Event Simulation Model to Evaluate the Impact of Treatment Sequences on Long-Term Patient Outcomes in Multiple Myeloma (MM)
3893 Improved Overall Survival with Enasidenib Compared with Standard of Care Among Patients with Relapsed or Refractory Acute Myeloid Leukemia and IDH2 Mutations: A Propensity Score Matching Analysis Using Data from the AG221-C-001 Trial and Two Data Sources from France and Germany